ImClone Investigational Site

Oshawa, Ontario L1G 2B9

0 studies enrolling now · 2 studies all time

What they study most

Colon Cancer, Colorectal Neoplasms, Metastases, Neoplasm, Rectal Cancer

Studies at this site

• A Study of Ramucirumab or Icrucumab in Colorectal Cancer — Completed
• Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy — Completed